With another trial win, Bristol Myers Squibb is touting Breyanzi as the CD19-directed CAR-T therapy with positive readouts in the most cancer types. | With another trial win, Bristol Myers Squibb is ...

BioSkryb Genomics, a Durham company focused on single-cell and ultra-low input multiomics, has introduced a new service called ResolveSEQ MRD, which allows more detailed classification and ...

Dec. 16, 2024 — Scientists have developed a new blood test that could screen ... risk in children with standard risk B-cell acute lymphoblastic leukemia (SR B-ALL), the most common childhood ...

However, these inhibitors can potentially increase the risk of secondary blood malignancies due to TNF alpha ... case study of a patient who developed Philadelphia-positive acute lymphoblastic ...

Marlise R. Luskin, MD, MSCE, speaks with Healio about findings from the phase 3 randomized Alliance A041501 trial.The study was put on hold due to grade 5 events among patients who received inotuzumab ...

WICHITA, Kan. (KWCH) - Kansas children battling leukemia have a new hope for survival thanks to a new treatment available in Wichita. KU School of Medicine-Wichita Doctors Nathan Hall and Brian Pate ...

The long-term safety of ibrutinib was proven in patients with newly diagnosed or relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). Quality-of ...

Fraser Wood, 7, was diagnosed with a type of blood cancer known as lymphoblastic lymphoma after becoming ill over the summer ...

24 Taken together, these data demonstrate that ΔTrkA is a very aggressive oncogene that transforms primary murine BM cells and induces both myeloid and lymphoblastic leukemia. Clonality studies ...

An international study published in the New England Journal of Medicine provides hope for chronic lymphocytic leukemia (CLL) ...

† Those without notes are either nonspecific or give too many clues of the diseases that cannot be listed. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; FDG PET-CT ...